Synlogic, Inc. (SYBX)
OTCMKTS · Delayed Price · Currency is USD
1.150
-0.025 (-2.13%)
At close: Sep 9, 2026
Synlogic Market Cap
Synlogic has a market cap or net worth of $13.45 million as of September 10, 2026. Its market cap has decreased by -21.78% in one year.
Market Cap
13.45M
Enterprise Value
268.14K
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.15
ChartMarket Cap Chart
Since August 28, 2017, Synlogic's market cap has decreased from 196.53M to 13.45M, a decrease of -93.16%. That is a compound annual growth rate of -25.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2026 | 13.45M | 2.66% |
| Dec 31, 2025 | 13.10M | -19.98% |
| Dec 31, 2024 | 16.37M | -53.72% |
| Dec 29, 2023 | 35.38M | -33.99% |
| Dec 30, 2022 | 53.60M | -68.23% |
| Dec 31, 2021 | 168.70M | 124.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Aug 28, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biomind Labs | 19.42M |
| EOM Pharmaceuticals Holdings | 19.11M |
| Finch Therapeutics Group | 16.62M |
| ZIVO Bioscience | 14.95M |
| Anebulo Pharmaceuticals | 14.63M |
| Oncotelic Therapeutics | 14.34M |
| Inhibitor Therapeutics | 12.87M |
| Brainstorm Cell Therapeutics | 11.59M |